Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 278 No 7453 p599
26 May 2007

This article
Reprint   Photocopy

  Acrobat Reader


News summary


NICE guideline issued on treating fever in under-5s

Monika Adamczyk/Dreamstime.com

Child's fever

Parents’ perception of their child’s fever should be taken seriously

How to assess and manage young children with a raised temperature is the subject of National Institute for Health and Clinical Excellence guidance published this week.

“Feverish illness in children: assessment and initial management in children younger than 5 years” is the first national guideline to provide all health care professionals— including pharmacists, GPs, nurses and paediatricians — with a practical “traffic light” tool to assess symptoms and decide whether a child needs to be referred to a specialist or may be treated at home.

The tool arranges signs and symptoms in columns — green (low risk), amber (intermediate risk) and red (high risk). A table of signs and symptoms suggestive of specific diseases is also given.

The guideline features a section on management by remote access which, it says, also applies to health care professionals whose scope of practice does not include the physical examination of children, for example, community pharmacists. This section advises health care professionals to identify any immediately life-threatening symptoms, including compromise of the airway, breathing or circulation, and decreased levels of consciousness. Children with these symptoms should be referred immediately for emergency medical care.

Children who have features in the red column but who are not considered to have an immediately life-threatening illness, should be urgently assessed by a health care professional in a face-to-face setting within two hours. Children with amber features should be assessed by a health care professional face-to-face within a timescale judged to be suitable by the remote assessor, and children with green features can be managed at home with appropriate advice, it says.

A section on antipyretic interventions recommends that antipyretics should not be used routinely in children with fever who are otherwise well but can be considered in those who appear distressed or unwell.

It adds that either paracetamol or ibuprofen can be used to reduce fever but advises that they should not be used at the same time and should not routinely be given alternately. Parental perception of a fever should be considered valid and taken seriously by health care professionals, NICE recommends.

Back to Top


©The Pharmaceutical Journal